Demeterherb details vitamin K2 specs for bone-health supplement lines

Demeterherb outlined how supplement brands can integrate vitamin K2 into bone-health products, highlighting MK-4 and MK-7 form selection, concentration, stability, and documentation. The guidance also points to HPLC testing, storage controls, and market-specific labeling as key steps for compliant product development.

Why it matters: - Vitamin K2 is used in bone-health supplement lines, but the active form, concentration, and dosage format must match the finished product. - Incorrect form selection can create formulation, stability, and batching problems, especially in low-dose systems. - Finished-product claims and warnings must stay within destination-market rules, including anticoagulant-related precautions.

What happened: - Demeterherb published a guide for integrating high-quality vitamin K2 powder into supplements. - The company says its Vitamin K2 offerings include MK-4 powder at 98% and MK-7 powder or oil at 0.1%, 0.2%, 0.45%, 1%, 1.3%, 1.5%, or 5%. - The listed MK-4 grade carries CAS 863-61-6, and the MK-7 grades carry CAS 2124-57-4. - The ingredient line is positioned for capsules, tablets, softgels, powder blends, and other supplement systems.

The details: - Demeterherb describes the Vitamin K2 series as all-trans, HPLC tested, light-yellow fine powder, and water-soluble. - The stated shelf life is 24 months when stored properly. - Storage guidance calls for a sealed container kept in a cool, dry, dark place below 25 degrees Celsius. - The company says every batch undergoes HPLC testing. - Documentation available for each order includes a COA, MSDS, and TDS. - The order file should identify the MK-4 or MK-7 form, concentration, all-trans status where applicable, carrier, solubility, shelf life, and packaging. - Demeterherb also offers private label support, customized packaging, and logistics options by express, air, sea, railway, and truck. - The company says it serves more than 50 countries and regions.

Between the lines: - The guide frames vitamin K2 as a controlled ingredient input, not a simple commodity. - The biggest development risk is mixing up a low-concentration MK-7 input with a higher-strength version, or substituting MK-4 for MK-7 without revising the formula. - The article draws a clear line between ingredient supply and finished-product compliance: Demeterherb provides the material and technical files, while the brand owner handles claims, serving levels, and warnings. - The guidance also reflects a common supplement-industry reality: raw-material quality alone does not guarantee finished-product stability.

What's next: - Product teams are expected to choose MK-4 or MK-7 first, then set concentration, confirm HPLC and all-trans data, and test stability in the final dosage form. - Brands entering new markets will need label review before launch, especially for bone-health claims and warfarin-related warnings. - Developers can request specifications, samples, technical documents, packaging options, private label plans, and quotes through Demeterherb's website.

The bottom line: - Vitamin K2 supplementation is less about the nutrient label and more about form, concentration, documentation, and stability discipline.